Golombick, Terry <br/><br/>
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.  [electronic resource] 

 -  American journal of hematology  May 2012 
 - 455-60 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.23159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Amino Acids--urine<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Biomarkers<br/>Bone Remodeling--drug effects<br/>Creatinine--blood<br/>Cross-Over Studies<br/>Curcumin--administration & dosage<br/>Disease Progression<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunoglobulin Light Chains--analysis<br/>Male<br/>Middle Aged<br/>Monoclonal Gammopathy of Undetermined Significance--blood<br/>Multiple Myeloma--prevention & control<br/>Myeloma Proteins--analysis<br/>Parathyroid Hormone--blood<br/>Treatment Outcome<br/>Vitamin D--blood